| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5318709ebf1fa2152a71cb8513c2dd73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8121 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
1997-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f86ffd84db72172ee73ad851b2bc68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e1af21fcc74c6868642d3c2bf93f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfa0b518fd39ea5376479c2a75341ea6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd58ee8b4135f5f5c630b3234e7c788 |
| publicationDate |
1999-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H1160500-A |
| titleOfInvention |
Blood coagulation hyperactivity inhibitor |
| abstract |
(57) [Summary] [Objective] To provide an agent capable of suppressing an abnormal increase in the blood coagulation system observed in disseminated intravascular coagulation and the like. The present invention relates to an agent for suppressing abnormal blood coagulation comprising a protein C inhibitor having a molecular weight of 54 to 57 kDa (SDS-PAGE), which suppresses the enhancement of the blood coagulation system as an active ingredient. [Effect] By intravenously administering the protein C inhibitor of the present invention, there is no fear of side effects such as bleeding tendency, It can suppress typical enhancement of the coagulation system seen in disseminated intravascular coagulation and the accompanying secondary enhancement of the fibrinolytic system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002010783-A |
| priorityDate |
1997-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |